Editor’s Note: We believe the “bird flu” is a manufactured crisis intended to allow the powers-that-be a path to introduce new pathogens into the food supply, reduce and control protein production, or both. The article below offers conclusions that we don’t necessarily believe, but it’s important for everyone to be aware of the narrative that’s being spread. I encourage everyone to read through the article to gain an understanding of the agenda being laid out before us.
(The Epoch Times)—With highly pathogenic avian influenza driving up egg prices in the United States to unprecedented heights, government officials are beginning to consider the use of vaccines to combat the illness.
The decision is complex because vaccination would instantly cut off more than half of the United States’ poultry exports due to trade provisions that forbid vaccination.
Even before any vaccine is approved, government officials are talking to international partners to soften the blow on the U.S. chicken export business in the eventuality that the United States deploys a vaccine.
Bird flu and the culling measures taken to attempt to stop its spread have wiped out 166 million birds in the United States since the current outbreak began in February 2022. This has driven up egg prices and triggered isolated shortages around the nation.
Over the past decade, the United States has faced two large outbreaks of H5N1 highly pathogenic avian influenza, or bird flu. The first outbreak, which occurred over the winter of 2014–15, hit the egg and turkey industries hard but was halted through the culling of sick birds, movement controls, and strict biosecurity measures.
The current bird flu outbreak has continued almost nonstop since February 2022 and the old strategy has so far failed to break the tide of the infection. As a result, both producers and regulators are considering a vaccine as a solution, even though it could cause extensive damage to the lucrative chicken export business.
Vaccination on the Table
The crisis has drawn the attention of the White House. During an address to a joint session of Congress on March 4, President Donald Trump said the price of eggs was “out of control” and called on his Secretary of Agriculture, Brooke Rollins, to “do a good job” of handling the issue.
Rollins announced the first step in carrying out that objective on Feb. 26. Along with committing as much as $1 billion to fight bird flu and drive down egg prices, Rollins announced the USDA will be taking the extraordinary step of exploring “vaccines, therapeutics, and other innovative solutions to minimize depopulation of egg-laying chickens.”
Using a vaccine is a tricky subject in the poultry world because of the significant potential international trade impacts.
Greg Tyler, the president and CEO of the USA Poultry and Egg Export Council, told The Epoch Times that if the United States started vaccinating today, as much as $3 billion worth of the country’s $5.8 billion poultry export market could be instantly closed off.
A senior USDA official who spoke with The Epoch Times confirmed that the agency considers vaccination an option to fight bird flu but it hasn’t made any final decisions and won’t rush to make any.
Rollins, the official said, understands the complexity of the issue and will consult with all parties in state governments, the agriculture industry, and the international trade community before making any decision.
The official said Rollins understands that vaccination is not the only solution to the country’s bird flu problem and may well not be the best possible solution. Logistically, the official said, vaccinating birds would be difficult as the technology does not yet exist for a dose to be administered without physically injecting birds.
The USDA has not yet approved any bird flu vaccine for use in the United States.
Tyler said he’s aware of a governmental effort to present a vaccination plan to the U.S.’s major trading partners to solicit each country’s feedback and, therefore, minimize trade impacts. Previously, he said, government officials were rushing to vaccination as a “quick fix” to drop egg prices. Still, he said the education offered by the poultry industry and elected officials from states with a significant poultry industry led to a more measured approach surrounding vaccination.
Ultimately, Tyler said the U.S. poultry industry wants to move ahead with vaccination if it helps the domestic egg industry, but a solution that doesn’t interfere with the massive U.S. export business needs to be found.
Risks and Rewards
The scale of the outbreak and the prevalence of potential disease vectors demonstrate that vaccination may well be in the future for the U.S. egg industry.
In a previous interview, Carol Cardona, a professor in the Department of Veterinary and Biomedical Sciences at the University of Minnesota, said bird flu is on the precipice of becoming endemic among wild bird populations in North America. Wild birds are considered the primary transmitter of the disease. However, Cardona said that recent research shows bird flu is now present in mammalian populations, including cats and dogs.
As the disease continues to spread to other species and mutate, Cardona predicted that vaccination may be “the next step” in combating the disease as new infections and culls are occurring at a much faster rate than the industry can replace productive birds.
The egg industry, in particular, is pushing for a vaccine rollout.
In testimony before the U.S. Senate Committee on Agriculture, Nutrition, and Forestry on Feb. 26, Tony Wesner, CEO of Indiana-based egg producer Rose Acre Farms, spoke at length about the egg industry’s trials during the past three years and its priorities going forward.
Wesner told the committee that the previous 2014-2015 outbreak was defeated by stamping out or culling infected flocks and strict isolation measures because the virus was primarily spread from one farm to another in so-called lateral transmission. This time around, wild birds and other vectors are circumventing biosecurity measures.
Wesner, speaking on behalf of a national egg farmers alliance called the United Egg Producers, recommended the United States adopt an “aggressive, forward-looking strategy for vaccination.”
Specifically, the egg industry would like to see the USDA stockpile bird flu vaccines, research delivery methods other than injection, establish a plan that would minimize risk to the U.S. export market, and begin field trials as soon as possible on an isolated layer flock located in Hawaii.
In a statement, the United Egg Producers said it believes using a vaccine as part of a broad disease control strategy would significantly reduce the risk of viral circulation among commercial poultry flocks, reduce viral shedding that could infect other flocks and animals, and lower the overall economic shocks caused by the spread of bird flu.
The United States’s overall egg-laying flock, however, is dwarfed by its counterparts who were raised to be slaughtered for meat. According to data published by the U.S. Poultry & Egg Association about 9.4 billion so-called broiler chickens were slaughtered for meat in 2023. By comparison, in 2022, the United States had 308 million commercial laying hens in the field, according to the United Egg Producers.
Because the United States produces so much chicken meat—about 61 billion pounds in 2023—a significant amount is exported. American producers exported more than 7 billion pounds of chicken in 2023, according to the U.S. Poultry and Egg Association.
Tyler said many of the most important export destinations for that meat maintain provisions that would ban poultry imports from the United States if vaccination begins. These triggers are based on fears that the meat or live poultry imported as breeding stock would bring the disease into the receiving country.
In a statement released on Feb. 21, the National Chicken Council (NCC), an industry group representing chicken meat processors and packers, said the broiler industry does and will continue to oppose any vaccination plan that does not include “robust trade protections.”
“The industry least affected by bird flu stands to lose the most with a vaccination strategy without trade protections,” David Elrod, the NCC’s director of government affairs, said in the statement.
One notable test balloon has already been floated. In the recent past, France began vaccinating poultry against bird flu and was subsequently banned from most international trade, Tyler said. However, exports are starting to open up again for the European nation if it can prove to its trading partners that the product did not originate in a region where vaccination is occurring.
Tyler said that there is a growing realization in the global poultry industry that bird flu is a worldwide problem. With France out of the gate on vaccination, everyone is now looking for a bigger market to test targeted vaccination and so-called trade compartmentalization.
“They’re looking for someone to step out and say, ‘Okay, this is how it could be done,’” Tyler told The Epoch Times. “I think we may see more countries come forth with the interest of vaccinating once the U.S. starts a vaccination program.”
Human Health Questions
A senior USDA official told The Epoch Times that one key reason for maintaining the practice of culling—even in the face of real inflationary impacts—is the desire to prevent the virus from mutating and becoming a serious human health problem. If that were to happen, egg prices would be a minor problem by comparison.
Cardona said the global experience with bird flu over the past three decades, its high propensity to mutate, and current transmission among mammals all point toward the disease regularly infecting humans in the future. When that happens, public health authorities will need to ask themselves serious questions about mass vaccination to protect human health.
Dr. Robert Malone, a vaccine pioneer known for his skepticism of the U.S. public health establishment’s approach to COVID-19, said the bird flu virus is known for “drifts and shifts” in its genetics. Still, he isn’t yet concerned about the human health risk presented by bird flu.
Rather, he told The Epoch Times, he is worried that a “leaky” mRNA vaccine administered to birds en masse will speed up the creation of a vaccine-resistant variant of bird flu. Just like U.S. trading partners, he is also concerned that vaccination can mask the presence of the virus.
“Farm workers will be exposed to infected flocks that aren’t showing disease as prominently,” Malone said. “If the virus does jump into humans, then it’s already evolved to escape immune surveillance to some extent. Those are not good things.”
Safeguarding Your American Dream: Discover the Power of America First Healthcare
In today’s economy, healthcare costs remain one of the biggest threats to financial stability and family security. Americans work hard to build a better life, yet rising medical expenses can quickly erode savings, force tough trade-offs, and even push families toward debt or bankruptcy. Medical bills continue to rank as the leading cause of personal bankruptcy in the United States, with millions facing underinsurance or unexpected out-of-pocket burdens that no one plans for. Many turn to government-run marketplace plans under the Affordable Care Act, hoping for relief, only to discover that what appears affordable on paper often delivers higher long-term costs, limited real protection, and coverage that may not align with personal values or family needs.
America First Healthcare stands out as a private insurance agency dedicated to helping conservatives and families secure better coverage and better rates through customized, values-aligned options. By conducting free insurance reviews, the agency uncovers hidden gaps in existing policies and connects clients with private alternatives that emphasize personal responsibility, small-government principles, and genuine affordability—often delivering up to 20% savings while providing stronger protection for the American Dream.
The allure of marketplace plans is easy to understand: open enrollment periods, premium tax credits for many households, and the promise of “comprehensive” benefits mandated by law. Yet recent data reveals a different reality, especially after the expiration of enhanced premium subsidies at the end of 2025. Enrollment for 2026 dropped by more than one million people compared to the prior year, with many shifting to lower-tier bronze plans to keep monthly premiums manageable.
These plans feature significantly higher deductibles—averaging around $7,500 nationally—and greater cost-sharing requirements. Families who once paid modest amounts after subsidies now face average premium increases of $65 or more per month, even as they accept plans that leave them responsible for thousands in upfront costs before meaningful coverage kicks in.
High deductibles create a dangerous barrier to care. Studies show that people in such plans are less likely to seek timely treatment for chronic conditions, attend preventive screenings, or fill necessary prescriptions. A seemingly minor illness or injury can balloon into major expenses when patients delay care until problems worsen. For a family of four, a single hospitalization, cancer diagnosis, or unexpected surgery can easily exceed the deductible, triggering coinsurance and out-of-pocket maximums that still leave substantial bills. One recent analysis noted that some proposed changes could push family deductibles toward $31,000 in future years, further exposing households to financial risk.
Beyond the numbers, marketplace plans often carry structural limitations. Coverage for certain critical services may include waiting periods or narrower networks that restrict access to preferred doctors and specialists. Preventive care is required to be covered without cost-sharing, but everything else—lab work, imaging, specialist visits, or ongoing treatment—typically waits until the deductible is met. This reactive model contrasts sharply with the proactive, holistic approach many families prefer, especially those focused on wellness, early intervention, and maintaining health to enjoy life rather than merely reacting to illness.
Values alignment represents another growing concern. Government-influenced plans operate within a framework shaped by federal mandates and political priorities that may not reflect conservative principles of limited government, personal freedom, and ethical stewardship. Families who want to direct their healthcare dollars toward providers and benefits that honor traditional values sometimes find marketplace options feel misaligned, forcing a compromise between affordability and conviction.
Private alternatives, by contrast, offer year-round flexibility without the restrictions of open enrollment windows. Independent agents can shop across a wider range of carriers to design plans tailored to specific family needs—whether that means lower deductibles for frequent medical users, broader provider networks, or add-ons that support wellness and preventive services from day one. Clients frequently report more stable premiums that do not automatically escalate each year, along with genuine cost savings once the full picture of deductibles, copays, and coverage depth is considered.
Take the experience of real families who made the switch. Amanda C. shared that her new plan felt “way better” than what she had through the marketplace. Johnny Y. noted his previous coverage kept increasing annually until he found a more stable private option. Sofia S. expressed delight with her plan and began recommending it to others. These stories echo a common theme: when families move beyond one-size-fits-all government marketplaces, they often discover customized protection that better safeguards both health and finances.
Founder Jordan Sarmiento’s own journey underscores the stakes. In 2021, a six-day hospitalization generated a $95,000 bill. Under a well-structured private “Conservative Care Coverage” plan, his out-of-pocket responsibility would have been just $500. That stark difference illustrates how thoughtful planning and private options can prevent a medical event from becoming a financial catastrophe.
Practical steps exist for anyone questioning their current coverage. Start with a no-obligation review of your existing policy to identify gaps—high deductibles, limited critical-care benefits, or escalating premiums. Compare total projected costs (premiums plus potential out-of-pocket expenses) rather than monthly premiums alone. Consider family health history, anticipated needs, and lifestyle priorities. Private agencies can present side-by-side options that include stronger wellness incentives, broader access, and plans built on shared values of self-reliance and freedom.
In an era when healthcare inflation continues to outpace general cost-of-living increases, relying solely on marketplace solutions carries growing risk. Families who proactively explore private alternatives frequently achieve meaningful savings while gaining peace of mind that their coverage truly works when needed most.
America First Healthcare makes this exploration straightforward through its free review process. Families and individuals receive personalized guidance to close coverage holes, reduce unnecessary expenses, and secure plans that align with conservative principles—protecting wallets, health, and the American Dream without government overreach. Many who complete a review discover they can enjoy better benefits for less, often saving up to 20% while gaining the customization and stability that marketplace plans struggle to deliver.
Ultimately, protecting your family’s future requires looking beyond the marketing of “affordable” government options. By understanding the long-term costs hidden in high deductibles, shifting coverage tiers, and values mismatches, Americans can make empowered choices. Private, values-driven insurance offers a smarter path—one that rewards diligence, supports wellness, and delivers real security. For those ready to move beyond the limitations of traditional marketplace plans, a simple review can reveal options designed to serve families, not bureaucracies. The American Dream thrives when individuals and families retain control over their healthcare decisions, and thoughtful private coverage plays a vital role in making that possible.